Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
      • Atlanta
        • Atlanta Leadership
        • Atlanta Contacts
      • Caribbean
        • Caribbean Leadership
        • Caribbean Contacts
      • Chicago
        • Chicago Leadership
        • Chicago Contacts
      • Dallas
        • Dallas Leadership
        • Dallas Contacts
      • Detroit
        • Detroit Leadership
        • Detroit Contacts
      • El Paso
        • El Paso Leadership
        • El Paso Contacts
      • Headquarters
      • Houston
        • Houston Leadership
        • Houston Contacts
      • Los Angeles
        • Los Angeles Leadership
        • Los Angeles Contacts
      • Louisville
        • Louisville Leadership
        • Louisville Contacts
      • Miami
        • Miami Leadership
        • Miami Contacts
      • New England
        • New England Leadership
        • New England Contacts
      • New Jersey
        • New Jersey Contacts
      • New Orleans
        • New Orleans Leadership
        • New Orleans Contacts
      • New York
        • New York Leadership
        • New York Contacts
      • Omaha
        • Omaha Leadership
        • Omaha Contacts
      • Philadelphia
        • Philadelphia Leadership
        • Philadelphia Contacts
      • Phoenix
        • Phoenix Leadership
        • Phoenix Contacts
      • Rocky Mountain
        • Rocky Mountain Contacts
      • San Diego
        • San Diego Leadership
        • San Diego Contacts
      • San Francisco
        • San Francisco Contacts
      • Seattle
        • Seattle Contacts
      • St. Louis
        • St. Louis Leadership
        • St. Louis Contacts
      • Washington, DC
        • Washington Leadership
        • Washington Contacts
    • DEA Museum
    • Oficinas extranjeras
      • Africa
      • Andean
      • Caribbean
      • Europe
      • Far East
        • Far East Region Leadership
      • Middle East
      • North and Central America
      • Southern Cone
    • Divisiones operativas
      • División de Aviación
      • División de Control de Desvíos
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Lo que hacemos
    • Orden público
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
        • Leadership
        • Mission
        • Services
        • Contacts
      • Forensic Sciences
        • Computer Forensics Program
        • Environmental Management
        • Laboratories
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
        • State and Local Task Forces
    • Educación y prevención
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Red Ribbon
        • Kiki and the History of Red Ribbon Week
        • Red Ribbon Toolkit - Resources For Your Community
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Información sobre las drogas
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Carreras
    • Agentes especiales
      • Preguntas frecuentes de los agentes especiales
      • Anuncios de empleo para agentes especiales
    • Investigador de desvíos
      • Diversion Investigator Job Announcement
    • Especialista en investigación de inteligencia
      • Anuncios de trabajo de especialista en investigación de inteligencia
      • Preguntas frecuentes de los especialistas en investigación de inteligencia
      • Autoridad de contratación de la Categoría A: Especialista en investigación de inteligencia
    • Carreras de ciencias forenses
    • Carreras profesionales y administrativas
    • Carreras para estudiantes y de nivel básico
    • Cómo aplicar
      • Empleador con igualdad de oportunidades
      • Requisitos de empleo
      • Cómo reclamar la preferencia de los veteranos
      • Consideración prioritaria
      • Beneficios
      • Veteranos y personas con discapacidades
  • Recursos
    • Recovery Resources
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • Ley de Libertad de Información
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Victim Witness Assistance Program Resources

United States Drug Enforcement Administration

  • Buscar
  • Menú Completo

Main Menu

  • Quiénes somos
  • Lo que hacemos
  • Carreras
  • Recursos
  • Recibir Actualizaciones
  • Scam Alert
  • English
  • ES

PUBLIC SAFETY ALERT

DEA Reports Widespread Threat of Fentanyl Mixed with Xylazine - DEA Reports Widespread Threat of Fentanyl Mixed with Xylazine

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2023 (19)
  • 2022 (107)
  • 2021 (70)
  • 2020 (11)
  • 2019 (3)
  • 2018 (1)
  • 2017 (1)
  • 2016 (1)

Subject

  • Drug Trafficking (2066)
  • Synthetic drugs (571)
  • Guns/Weapons (480)
  • OCDETF/Task Force (328)
  • Seizures (Drugs/Property) (308)
  • Guilty Plea (297)
  • Arrests/Convictions - Major (249)
  • Prescription Drugs (208)
  • Major Law Enforcement Operation (203)
  • Task Forces/Task Force Officers (191)
  • Fake Pills (189)
  • Overdose (180)
  • Pharmaceuticals/Pharmacists/Physicians (153)
  • Take Back Day (134)
  • Gangs (115)
  • Money Laundering (102)
  • Outreach/Drug Prevention (89)
  • HIDTA (60)
  • Narcoterrorism (42)
  • Prevention/Education - DEA websites GSAD, JTT etc (36)
  • Dark Web- Internet Trafficking (21)
  • International/Foreign Operations (21)
  • Red Ribbon (20)
  • Fentanyl Awareness (17)
  • Congressional Affairs (14)
  • One Pill Can Kill (12)
  • Asset Forfeiture (11)
  • Intergovernmental Affairs (7)
  • Critical Incident (5)
  • Scam Calls (4)
  • Terrorism (4)
  • Museum and Visitors Center (3)
  • Intelligence Division - Intelligence Products (2)
  • Diversion Division (112)
  • Press Conferences (45)
  • Public and Media Affairs - also see Congressional Affairs (40)
  • Extraditions (27)

Drug Name

  • Fentanyl (47)
  • Opioids (30)
  • Cocaine (29)
  • Oxycodone (28)
  • Methamphetamine (19)
  • Heroin (15)
  • Synthetic Opioids (13)
  • Hydromorphone (7)
  • Morphine (5)
  • Marijuana (Cannabis) (4)
  • Steroids (3)
  • Amphetamines (2)
  • Benzodiazepines (2)
  • Methadone (2)
  • Ecstasy/MDMA (1)
  • Ketamine (1)

Field Division

  • Washington, DC (46)
  • Sede (25)
  • New York (19)
  • New Jersey (16)
  • Chicago (15)
  • Seattle (12)
  • El Paso (11)
  • Dallas (10)
  • Miami (10)
  • New England (10)
  • Omaha (7)
  • Atlanta (5)
  • Rocky Mountain (5)
  • St. Louis (4)
  • Houston (3)
  • New Orleans (3)
  • San Diego (3)
  • Detroit (2)
  • Los Angeles (2)
  • Caribe (1)
  • Louisville (1)
  • Philadelphia (1)
  • Phoenix (1)
  • San Francisco (1)
Clear All Results

Law Enforcement Partners Host Second Annual Nebraska Drug Forum

Marzo 29, 2023
KEARNEY, Neb. – As drug trends change and overdose incidents increase across the country, law enforcement partners continue working to counter the threat to Nebraska communities through enforcement and education. That ongoing partnership was on display for law enforcement agencies and county attorneys during this week’s second annual Nebraska Drug...

Colorado Pharmacy and Pharmacist Agree to Resolve Allegations that They Unlawfully Filled Dangerous Prescriptions for Controlled Substances

Marzo 27, 2023
DENVER — The United States Attorney’s Office for the District of Colorado announced that People’s Pharmacy, Inc. and its owner and pharmacist-in-charge, Mahnaz Abharian, have agreed to resolve allegations that the pharmacy unlawfully dispensed controlled substances, including dangerous opioids and drug combinations. People’s Pharmacy operated a pharmacy located in Lakewood...

Indianapolis Pharmacy Technician Charged with Controlled Substances Violations

Marzo 24, 2023
INDIANAPOLIS - A joint investigation by Drug Enforcement Administration-Indianapolis and the Indianapolis Metropolitan Police Department (IMPD) has led to the arrest of Zennon Gaines, a pharmacy technician from Indianapolis, who has been charged with multiple violations, including felony dealing and possession of a controlled substance by fraud/forgery. The joint investigation...

Panama City Physician Pays $225,000 to Settle Allegations that He Overprescribed Controlled Substances

Marzo 21, 2023
PENSACOLA, Fla. – Dr. George Barrio, a pain management physician who formerly practiced medicine at the NeuroMedical Institute in Panama City, agreed to pay $225,000 to resolve allegations that he unlawfully prescribed opioids and other controlled substances to patients. The settlement was announced by Jason R. Coody, United States Attorney...

Rocky Mountain Diversion Investigator Named “Outstanding Citizen of the Year”

Marzo 17, 2023
Bozeman, Mont. – Rocky Mountain Division Diversion Investigator (DI) Aaron St. Peter was recently named “Outstanding Citizen of the Year” at the Montana Narcotic’s Officers Association (MNOA) Conference in Bozeman. DI St. Peter was nominated by a colleague from the Montana Department of Justice, Criminal Investigation Division (MT CID). The...

Greenwood Village Psychiatrist Pleads Guilty to Illegal Distribution of Controlled Substances and Financial Crimes

Marzo 09, 2023
DENVER – Howard Weiss of Greenwood Village pleaded guilty on March 8, 2023 to distributing a controlled substance outside the usual course of professional practice and for no legitimate medical purpose, structuring financial transactions in a way to evade reporting requirements, and engaging in monetary transactions greater than $10,000 in...

Indiana Man Sentenced to 5 Years' Probation for Obtaining a Controlled Substance by Deception

Marzo 08, 2023
FORT WAYNE, Ind. – Alfred A. Cooke, Assistant Special Agent in Charge of Drug Enforcement Administration-Merrillville, Indiana, and U.S. Attorney Clifford D. Johnson for the Northern District of Indiana announced that Lucian Boboia, age 49, of Phoenix, Arizona, was sentenced before U.S. District Court Judge Holly A. Brady after pleading...

Laurence Doud, Former CEO of Pharmaceutical Distributor, Sentenced to 27 Months in Prison for Conspiring to Unlawfully Distribute Controlled Substances and Defrauding the DEA

Marzo 08, 2023
Damian Williams, the United States Attorney for the Southern District of New York, announced that LAURENCE F. DOUD III, the former Chief Executive Officer of Rochester Drug Co-Operative, Inc. (“RDC”), was sentenced today in Manhattan federal court to 27 months in prison for conspiring to unlawfully distribute oxycodone and fentanyl...

DOJ and Lincoln Pharmacy in Tacoma Settle Allegations the Pharmacy Failed to Follow the Controlled Substances Act

Febrero 28, 2023
SEATTLE – The U.S. Attorney’s Office and Lincoln Pharmacy in Tacoma have reached a settlement agreement over inspection findings by the Drug Enforcement Administration that Lincoln had failed to comply with some of the administrative requirements of the Controlled Substances Act (CSA). Lincoln Pharmacy will pay the United States $80,000...

Former Nurse Indicted for Drug Diversion from Boston Hospital

Febrero 27, 2023
BOSTON – A former nurse has been indicted by a federal grand jury in Boston for allegedly diverting opioids from a Boston-area hospital. Andrea Falzano, 38, of Winchester, was indicted on three counts of unlawfully obtaining controlled substances by fraud, deception and subterfuge. Falzano was arrested this morning and will...
Showing 1 - 10 of 213 results

Paginación

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Siguiente página ›
  • Última página »

SAMHSA Behavioral Health Treatment Locator

  • Quienes Somos
    • Sobre
    • Divisiones Nacionales
    • Oficinas Extranjeras
    • Contáctenos
    • Museo DEA
  • Lo Que Hacemos
    • Prevención de Drogas
    • Aplicacion de la Ley
    • División de Control de Desvío
    • Noticias
  • Carreras
    • Resumen
    • Agente Especial
    • Investigador de Desvío
    • Especialista en Investigación de Inteligencia
  • Recursos
    • Información sobre las Drogas
    • Programa de Asistencia al Empleado
    • Empleador con Igualdad de Oportunidades
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Hacer Negocios
    con la DEA
    • Resumen
    • Proveedores Actuales
    • Futuros Vendedores
    • Cláusulas de Seguridad
    • Formularios de Seguridad
    • Programa de Pequeñas Empresas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
Inicio

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook Twitter LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster